Abdulaziz Yalınkılıç

Abdulaziz Yalınkılıç

Auto-generated profile, based on publicly available information

Abdulaziz Yalınkılıç

Van Yuzuncu Yil Universitesi

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2026 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
AYAbdulaziz Yalınkılıç
Abdulaziz Yalınkılıç
ZHZübeyir Huyut
Zübeyir Huyut
MAMehmet Edip Akyol
Mehmet Edip Akyol
DGDamla Ayan Gündemir
Damla Ayan Gündemir
Mehmet Tahir HUYUTMehmet Tahir HUYUT
Mehmet Tahir HUYUT
YCYaser Said Cetin
Yaser Said Cetin
Objective : Prestin, expressed in cochlear outer hair cells, is essential for auditory signal amplification and may serve as a biomarker for cochlear injury related to trauma. This study aimed to investigate the potential role of prestin in the diagnosis and prognosis of cranial trauma.Methods : A total of 150 participants were included, comprising 110 patients aged 18–70 who were treated for head trauma and 40 age-matched healthy controls. The patients were divided into two groups of 55 each, with Glasgow coma scale (GCS) ≥13 and GCS ≤8, according to the GCS. Prestin was measured by enzyme-linked immunosorbent assay in serum on days 1, 3, and 7 in the patient and also the control groups. In the diagnosis of trauma and determining trauma severity, important risk levels (cut-off values) according to prestin's measurement days were calculated by receiver operating characteristic (ROC) analysis.Results : Prestin values in both the GCS ≥13 and GCS ≤8 groups were dramatically lower than those in the control on all measurement days. Additionally, prestin values in the GCS ≤8 group on days 3 and 7 tended to be lower than those in the GCS ≥13 group. Furthermore, there was a tendency for serum prestin values to increase as time progressed especially in the GCS ≥13 group. ROC analysis showed that prestin values on the first, third, and seventh days showed high accuracy in detecting traumatized individuals with area under the curve (AUC) values of 85%, 81%, and 75%, respectively (sensitivity : 84%, 79%, and 83%, respectively). Also, prestin data on the first day accurately detected the severity of trauma at a high rate (sensitivity, 82%; AUC, 90%).Conclusion : Our findings suggest that serum prestin levels on the first day after trauma may provide supportive information regarding trauma severity. However, further controlled studies are needed before definitive diagnostic or prognostic use.

11 November 2024 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
AYAbdulaziz Yalinkiliç
Abdulaziz Yalinkiliç
FYFatma Ayaz Yalinkiliç
Fatma Ayaz Yalinkiliç
BBBurhan Beger
Burhan Beger
MEMehmet Zeki Erdem
Mehmet Zeki Erdem
HUHadice Msc Uçar
Hadice Msc Uçar
OBOrhan Beger
Orhan Beger
Objective: This study aimed to investigate the efficacy of infliximab, a TNF-α inhibitor, on epithelial damage, inflammation, and fibrosis in experimental tracheal stenosis. Methods: Rats were divided into 3 groups. In group 1 (the control group), no procedure was applied. Tracheotomy was opened in the other groups. The laryngotracheal mucosa of the rats was traumatized with a brush through the tracheostoma to create a stenosis model. After surgery, group 2 (the infliximab group) received 5 mg/kg infliximab intraperitoneally. In group 3 (the sham group) only 0.5 ml of saline (0.9% NaCl) was administered intraperitoneally. After 14 days, the rats were sacrificed. Tracheal rings were excised, and epithelial damage, inflammation, and fibrosis were evaluated histopathologically. Results: Infliximab reduced the formation of epithelial damage (P=0.002), fibrosis (P=0.001), and inflammation (P=0.003) compared with the sham and control group. Conclusion: This was the first investigation displaying the effects of infliximab on tracheal stenosis. The authors' experimental results may offer guidance for further studies. Their experience presents novel sights into optimizing outcomes in tracheal stenosis surgery, and so paves the way for further clinical examinations.

15 September 2025 in Online Türk Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
AYAbdulaziz Yalınkılıç
Abdulaziz Yalınkılıç
MEMehmet Zeki Erdem
Mehmet Zeki Erdem
MAMehmet Aydın
Mehmet Aydın
SASemra Ağırbaş
Semra Ağırbaş
MIMesut Işık
Mesut Işık
Objective: Chronic sore throat is one of the common causes of presentation to otolaryngology outpatient clinics. Although non-infectious causes are usually blamed, it is thought to be related to many etiologic factors. In this study, psychological factors associated with chronic sore throats, especially anxiety, depression, somatosensory amplification, and somatization, were examined. Materials and Methods: The study was conducted with 77 participants, including 41 patients with chronic sore throat and 36 healthy controls. Sociodemographic data and psychological assessments using the Hospital Anxiety and Depression Scale (HAD), Somatization Scale, and Somatosensory Amplification Scale (SAS) were collected. Results: No significant differences were found between groups in terms of age, gender, smoking habits, psychiatric history, or ongoing psychiatric treatment. Somatization Scale and SAS scores were significantly higher in the patient group (p=0.001 and p=0.005). No significant differences were found in HAD-A and HAD-D scores between the patient and control groups. However, a significant positive correlation was observed between HAD-A and SAS scores. Conclusions: Psychological factors, particularly somatosensory amplification, may contribute to the persistence of chronic sore throat. These findings highlight the importance of incorporating psychological assessments in the management of such cases to improve diagnostic accuracy and treatment outcomes.

16 March 2026 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Open access
PDF file
BABilal Arslan
Bilal Arslan
FYFatma Ayaz Yalınkılıç
Fatma Ayaz Yalınkılıç
AEAdnan Erseçkin
Adnan Erseçkin
BBBurhan Burhan Beger
Burhan Burhan Beger
BABilal Acar
Bilal Acar
HDHalit Demir
Halit Demir
This study aimed to investigate the histopathological and biochemical neuroprotective effects of IL-1 receptor antagonist (anakinra) administration in an asphyxia-induced cardiac arrest model. A total of 24 Wistar albino rats were randomized into three groups: control, sham (cardiac arrest + saline), and anakinra (cardiac arrest + 50 mg/kg anakinra). Brain tissues were evaluated using a six-parameter semi-quantitative histopathological scoring system, and the composite damage score (CDS) was calculated (0–12). Levels of antioxidant and oxidative markers SOD, CAT, GSH, and MDA were analyzed spectrophotometrically. In the anakinra-treated group, neuronal degeneration, gliosis, and neuropil edema levels were significantly lower compared to the sham group ( p < 0.01 for all). Although vascular congestion and perivascular edema were observed to be lower in the anakinra group, this reduction was not statistically significant in score analyses compared to the sham group ( p > 0.05). No significant difference was found between the groups in terms of PMNL infiltration. In biochemical analyses, SOD, CAT, and GSH levels were found to be significantly higher in the anakinra group compared to both the sham and control groups ( p < 0.001), while MDA levels were significantly lower ( p < 0.001). These findings indicate that anakinra reduces oxidative stress and significantly alleviates neurohistopathological damage in the experimental model. Anakinra administration significantly reduced short-term hypoxic-ischemic brain damage following cardiac arrest, both in terms of histopathological and oxidative stress parameters. The findings suggest that targeting the IL-1-mediated inflammatory response could be an important neuroprotective approach; however, further studies are needed regarding dose, timing of administration, and long-term neurological function.

30 June 2026 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Verified
Journal Article
Open access
FAFırat Aslan
Fırat Aslan
SBSerhat Binici
Serhat Binici
IEIKLIL ERYILMAZ
IKLIL ERYILMAZ
BBBurhan Burhan Beger
Burhan Burhan Beger
AYAbdulaziz Yalınkılıç
Abdulaziz Yalınkılıç
MKMehmet Cetin Kotan
Mehmet Cetin Kotan
Background:Intrathyroidal parathyroid glands represent a rare anatomical variant and are recognized as a potential risk factor for incidental parathyroidectomy during thyroid surgery. Their intraoperative identification is challenging due to their atypical localization.Methods:A retrospective analysis was performed on 4,231 thyroid surgeries conducted at a single center between January 2015 and December 2025. Patients with histopathologically confirmed intrathyroidal parathyroid tissue were included. Demographic data, type of surgery, histopathological findings, and pre- and postoperative serum calcium and PTH levels were evaluated. Postoperative hypocalcemia resolving within six months was defined as transient, whereas persistent hypocalcemia beyond six months was considered permanent.Results:Intrathyroidal parathyroid tissue was incidentally excised in 19 patients, corresponding to an incidence of 0.45%. All affected patients were female, with a mean age of 28.6 ± 11.4 years. Histopathological examination demonstrated that the majority of excised parathyroid glands were structurally normal. Transient hypocalcemia occurred in three patients (15.8%) and resolved within six months. No cases of permanent hypocalcemia were observed. No statistically significant changes were detected in postoperative calcium or PTH levels.Conclusion:Intrathyroidal parathyroid glands are an uncommon anatomical variant that may be incidentally excised during thyroid surgery. In this series, their removal was not associated with permanent hypocalcemia. These findings highlight the importance of anatomical variability in the evaluation of incidental parathyroidectomy and postoperative biochemical outcomes.